Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma
Document Type
Article
Publication Date
5-1-2023
Abstract
With the growing incidence of NAFLD on a global scale, management pathways and pharmacologic treatment options are eagerly awaited. Metabolic derangement in NAFLD associated with obesity is a key driver of disease progression and could be a useful target for pharmacologic intervention. Although NAFLD is more prevalent among individuals with obesity, an increasing prevalence among lean individuals has also been reported.
Keywords
Fatty liver, Hepatocellular carcinoma, Liver cancer, Liver cirrhosis, Nonalcoholic fatty liver, Nonalcoholic steatohepatitis
Divisions
medicinedept
Publication Title
CLINICS IN LIVER DISEASE
Volume
27
Issue
2
Publisher
W B SAUNDERS CO-ELSEVIER INC
Publisher Location
1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
COinS